PIONEERING BOTANICAL DRUG DEVELOPMENT


Ajna is creating transformative therapies that hold the potential to revolutionize medicine and enhance the lives of countless individuals around the world.

OUR STRATEGY


We focus on select plant and fungi species with a well- established history of therapeutic use, which streamlines the drug discovery process, mitigates late-stage clinical trial risk, and propels us towards unprecedented medicinal breakthroughs.

With a specialized infrastructure and industry expertise, we're strategically poised to lead and create significant value in this exciting, nascent category of pharmaceuticals.

THE PROBLEM


People want botanical pharmaceutical options, but few exist.

Plant medicines have been trusted for millennia, offering therapeutic benefits deeply rooted in cultural and historical practices. As modern pharmaceuticals often come with unintended side effects, a growing demand for botanical alternatives is evident. Ajna is building a bridge between what people want, and physician advocacy they can trust.

THE SOLUTION


Our unique drug development platform transforms medicinal plants into FDA-approved drugs.

1. RESEARCH

Source plant species with well established history of therapeutic use.

2. DEVELOP

Apply modern CMC and scientific instrumentation to characterize and standardize botanical raw materials to FDA standards.

3. STUDY

Initiate FDA clinical trials to prove safety and efficacy.

4. COMMERCIALIZE

Multiple go-to-market strategies including licensing, joint ventures, acquisitions, or complete vertical integration.

Our Competitive Advantage

FIRST MOVERS

With only 3 currently FDA approved botanical drugs, Ajna is strategically positioned to capture a considerable portion of this exciting new market category.

UNIQUE IP PROTECTION

Traditional Pharma firms face their greatest profitability threat from generics, but the intricate composition of our botanical mixtures makes them nearly impossible to replicate.

BARRIERS TO ENTRY

Selecting plant species with a well-established history of therapeutic use streamlines the drug discovery process and mitigates late-stage clinical trial risk.

SPEED TO MARKET & RISK MITIGATION

Rigorous CMC and regulatory requirements present substantial hurdles for future competitors seeking to enter the market.

THE MISSION FOR NEW MEDICINE


Join us in building a future where the incredible power of nature meets cutting-edge science.

Together, we have the remarkable opportunity to pioneer a new era of botanical drug development, creating transformative therapies that hold the potential to revolutionize medicine and enhance the lives of countless individuals around the world.

“Our field is the healing power of botanics and our purpose is to serve and better the planet through them. Through this new truth, we will pioneer a better future.”

Ajna Co-Founder and CEO
Former CEO and Chairman of the Board, Charlotte’s Web

Joel Stanley

Newsroom